Medistim ASA (0OCD) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Medistim Asa.

Watch the replay

Replay transcript excerpt

WEBVTT NOTE Transcription provided by Deepgram Request Id: 01a03fbd-15f6-7c63-8627-1bff69efa5fd Created: 2026-08-26T20:22:33.798Z Duration: 2976.8882 Channels: 1 00:00:00.240 -- 00:00:01.919 Very good morning, everyone, 00:00:02.240 -- 00:00:04.160 and welcome to Medistim's 00:00:04.160 -- 00:00:07.120 Second Quarter and First Half twenty twenty six 00:00:07.120 -- 00:00:08.959 Financial Results Presentation. 00:00:09.679 -- 00:00:12.000 My name is Karl Krugsta, and together with 00:00:12.000 -- 00:00:14.799 CFO, Thomas Jakobsen, we are here to go 00:00:14.799 -- 00:00:15.599 through the results. 00:00:18.505 -- 00:00:21.945 As always, we like to just remind ourselves 00:00:21.945 -- 00:00:23.865 about Medistim's track record 00:00:24.025 -- 00:00:27.544 and we are looking back on decades of 00:00:27.785 -- 00:00:31.305 growth both in sales and in operating profit. 00:00:31.830 -- 00:00:34.150 And that has been our promise to our 00:00:34.150 -- 00:00:35.110 shareholders 00:00:35.110 -- 00:00:36.150 to deliver 00:00:37.190 -- 00:00:38.630 constant 00:00:39.190 -- 00:00:41.670 profitable growth also going forward. 00:00:42.390 -- 00:00:44.790 If you look at just the recent period 00:00:44.870 -- 00:00:48.375 from 2021 to 2025, we are looking to 00:00:48.855 -- 00:00:50.055 13% 00:00:50.055 -- 00:00:50.934 annualized 00:00:51.655 -- 00:00:53.575 growth in sales. 00:00:53.895 -- 00:00:54.934 So definitely 00:00:55.095 -- 00:00:57.495 a strong track record to look back on. 00:00:58.375 -- 00:01:00.775 So with that, we are entering into 00:01:01.380 -- 00:01:02.660 the second quarter. 00:01:03.860 -- 00:01:06.340 The second quarter last year was a strong 00:01:06.340 -- 00:01:07.220 comparable 00:01:07.460 -- 00:01:09.140 and we're seeing that we are beating it 00:01:09.1...